UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study

The Journal of urology, 2013-03, Vol.189 (3), p.1110-1116

2013

Volltextzugriff (PDF)

The metabolic waste ammonium regulates mTORC2 and mTORC1 signaling

Scientific reports, 2017-03, Vol.7 (1), p.44602, Article 44602

2017

Volltextzugriff (PDF)

A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection

BMC urology, 2012-06, Vol.12 (1), p.16-16, Article 16

2012

Volltextzugriff (PDF)

Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families

Breast cancer research : BCR, 2020-04, Vol.22 (1), p.36-36, Article 36

2020

Volltextzugriff (PDF)

MiR-210 Is Overexpressed in Tumor-infiltrating Plasma Cells in Triple-negative Breast Cancer

The journal of histochemistry and cytochemistry, 2020-01, Vol.68 (1), p.25-32

2020

Volltextzugriff (PDF)

The MicroRNA miR-210 Is Expressed by Cancer Cells but Also by the Tumor Microenvironment in Triple-Negative Breast Cancer

The journal of histochemistry and cytochemistry, 2017-06, Vol.65 (6), p.335-346

2017

Volltextzugriff (PDF)

Chromothripsis in an Early Recurrent Chordoid Meningioma

World neurosurgery, 2019-10, Vol.130, p.380-385

2019

Volltextzugriff (PDF)

Glioblastoma in a fingolimod-treated multiple sclerosis patient: Causal or coincidental association?

Multiple sclerosis and related disorders, 2020-06, Vol.41, p.102012, Article 102012

2020

Volltextzugriff (PDF)

Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer

Breast cancer research : BCR, 2014-11, Vol.16 (6), p.466-466, Article 466

2014

Volltextzugriff (PDF)

ApolipoproteinL1 is expressed in papillary thyroid carcinomas

Pathology, research and practice, 2016-07, Vol.212 (7), p.631-635

2016

Volltextzugriff (PDF)

Silencing of casein kinase 1 delta reduces migration and metastasis of triple negative breast cancer cells

Oncotarget, 2018-07, Vol.9 (56), p.30821-30836

2018

Volltextzugriff (PDF)

Abstract P2-14-12: B-immune interim analysis: A phase Ib/II study of durvalumab combined with dose-dense EC in a neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-14-12

2022

Volltextzugriff (PDF)

Antenatal Membranous Nephropathy and Type 2 (Axonal) Charcot-Marie-Tooth With Mutations in the Metallo-Membrane Endopeptidase Gene: A Call for Family Screening and Pharmacovigilance

Kidney international reports, 2021-07, Vol.6 (7), p.1981-1986

2021

Volltextzugriff (PDF)

Analysis of T-cell repertoires in early-stage breast carcinomas to evaluate tumor immunogenicity

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.11554-11554

2017

Volltextzugriff (PDF)

Abstract 392: Helicase-like transcription factor (HLTF) expression and gene methylation in FFPE colon tumors

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.392-392

2014

Volltextzugriff (PDF)

Nuclear localization of glutamate-cysteine ligase is associated with proliferation in head and neck squamous cell carcinoma

Oncology letters, 2016-06, Vol.11 (6), p.3660-3668

2016

Volltextzugriff (PDF)

Abstract P4-07-16: B-IMMUNE final analysis: a phase Ib/II study of durvalumab combined with dose-dense EC in a neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P4-P4-07-16

2023

Volltextzugriff (PDF)

Mise à jour 2021 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers infiltrants du sein en France

Annales de pathologie, 2021-11, Vol.41 (6), p.507-520

2021

Volltextzugriff (PDF)

Exposure of endothelial cells to physiological levels of myeloperoxidase-modified LDL delays pericellular fibrinolysis

PloS one, 2012-06, Vol.7 (6), p.e38810-e38810

2012

Volltextzugriff (PDF)

2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France

Annales de pathologie, 2014-10, Vol.34 (5), p.352-365

2014

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(48)
Webseiten
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(26)
Humans
(19)
Life Sciences
(14)
Female
(11)
Biological And Medical Sciences
(10)
Animals
(9)
Neurosciences & Neurology
(9)
Rats
(9)
Sciences Du Vivant
(9)
Breast Cancer
(7)
Immunohistochemistry
(7)
Neurosciences
(7)
Anatomie & Physiologie
(6)
Anatomy & Physiology
(6)
Cells, Cultured
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Middle Aged
(6)
Atherosclerosis
(5)
Biochemistry, Biophysics & Molecular Biology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study

The metabolic waste ammonium regulates mTORC2 and mTORC1 signaling

Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancer

A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection

Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families

MiR-210 Is Overexpressed in Tumor-infiltrating Plasma Cells in Triple-negative Breast Cancer

The MicroRNA miR-210 Is Expressed by Cancer Cells but Also by the Tumor Microenvironment in Triple-Negative Breast Cancer

Chromothripsis in an Early Recurrent Chordoid Meningioma

Glioblastoma in a fingolimod-treated multiple sclerosis patient: Causal or coincidental association?

Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer

ApolipoproteinL1 is expressed in papillary thyroid carcinomas

Silencing of casein kinase 1 delta reduces migration and metastasis of triple negative breast cancer cells

Abstract P2-14-12: B-immune interim analysis: A phase Ib/II study of durvalumab combined with dose-dense EC in a neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers

Antenatal Membranous Nephropathy and Type 2 (Axonal) Charcot-Marie-Tooth With Mutations in the Metallo-Membrane Endopeptidase Gene: A Call for Family Screening and Pharmacovigilance

Analysis of T-cell repertoires in early-stage breast carcinomas to evaluate tumor immunogenicity

Abstract 392: Helicase-like transcription factor (HLTF) expression and gene methylation in FFPE colon tumors

GEFPICS' guidelines for management of breast cancer tissue samples in the neoadjuvant setting

Nuclear localization of glutamate-cysteine ligase is associated with proliferation in head and neck squamous cell carcinoma

Abstract P4-07-16: B-IMMUNE final analysis: a phase Ib/II study of durvalumab combined with dose-dense EC in a neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers

Mise à jour 2021 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers infiltrants du sein en France

2021 update of the GEFPICS’ recommendations for HER2 status assessment in invasive breast cancer in France

Exposure of endothelial cells to physiological levels of myeloperoxidase-modified LDL delays pericellular fibrinolysis

2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France

Recommandations du GEFPICS pour la prise en charge des prélèvements dans le cadre du traitement néoadjuvant du cancer du sein

GEFPICS' guidelines for management of breast cancer tissue samples in the neoadjuvant setting

Suchergebnisse filtern